{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/6434d7b3aa32b20011cfcb4c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Tuesday, April 11, 2023","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/show-cover.png?height=200","description":"<p>Two contradictory federal court rulings on the legality of a pill used in medication abortions creates more uncertainty for abortion access in the United States and the FDA’s authority.&nbsp;Prescription digital therapeutics company Pear Therapeutics files for bankruptcy. And, UnitedHealth Group has acquired large New York-based physician group Crystal Run Healthcare. That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}